Medicare Coverage With Evidence Development for Drugs Approved for Alzheimer’s Disease: Which Study Designs and Data Sources Would Best Answer Medicare’s Questions?
Author(s)
Sean Tunis, MD, MSc, Rubix Health, LLC, Baltimore, MD, USA
This Discussion Group will focus on and feature speakers from the session Medicare Coverage with Evidence Development for Drugs Approved for Alzheimer’s Disease: Which Study Designs and Data Sources Would Best Answer Medicare’s Questions? (Monday, May 8, 4:45pm – 5:45pm).
Seating is limited.
Conference/Value in Health Info
2023-05, ISPOR 2023, Boston, MA, USA
Code
156
Topic
Health Policy & Regulatory